Mount Sinai Human Immune Monitoring Center (HIMC)

Don't miss the chance to collaborate with HIMC—together, we can accelerate revolutionary discoveries and push the boundaries of cancer treatment! Reach out today and be part of the next wave of scientific breakthroughs! 👩‍🔬🧑‍🔬

As 2024 comes to a close, the HIMC team would like to take a moment to express our heartfelt THANKS. We deeply appreciate your continued support and collaboration throughout the year. Wishing you a joyful holiday season filled with happiness, warmth, and all the best for 2025.

🌍HIMC is happy to 📢 the acceptance of our collaborative article with Dr. Matthew Cummings on sepsis subtyping in sub-Saharan Africa in AJRCCM, highlighting the need for globally inclusive investigations for sepsis pathobiology. Read more @atscommunity : doi.org/10.1164/rccm.2…

Congrats to Sam Miake-Lye on becoming a PhD candidate! 🎉 His work in clinical studies & ultra-high-plex cytokine/biomarker analysis for neurological diseases will fuel groundbreaking research. Wishing him an inspiring academic journey ahead!

A heartfelt thank you to Manishkumar Patel for his 14 years of dedicated service to HIMC, where he contributed immensely to immune profiling. We wish him all the best as he embarks on a new chapter in his career. His hard work, dedication, and friendship have been appreciated!

Highly educational talks from Mr. Evan Mills, VP of @OlinkProteomics, and Dr. Ted George, Senior VP of @RareCyte, at #PrIISM2024! They showcased the innovative Olink Explore HT & Orion Multiplex IF, both successfully implemented at HIMC to advance scientific research.

New milestone: HIMC becomes the first academic site in great New York region, as certified @OlinkProteomics Service Provider for Explore HT platform, to assay more than 5400 proteins per sample with high specificity! Contact us for more information.

Check out HIMC's data in the Phase III Lung-MAP S1400I Trial. Exceptional responders to immune checkpoint inhibitors and rapid progressors were analyzed using the @Olink soluble protein detection platform to confirm major signatures. Read more @CCR_AACR: aacrjournals.org/clincancerres/…

HIMC is proud to be the first academic site in the Northeast region to implement the powerful proteomics platform—Next generation ultrahigh-plex Olink Explore HT with with unprecedented 5,400+ protein plex in a single assay! 🧑‍🔬

Congratulations Dr. Matthew Park @MiriamMerad lab! 🎉 @MountSinaiHIMC on how our immune system imprinting on BM during a lifetime on Science! mountsinai.org/about/newsroom…

📢HIMC has met w. our Olink collaborators for the installation of the Olink Explore-HT with unprecedented 5,400+ protein plex! With the supporting effort of @OlinkProteomics, our first study data is coming VERY SOON‼️

Exciting news! 📢HIMC has implemented @RareCyte Orion high-plex immunofluorescence imaging instrument to investigate the local tissuemicroenvironment! Check out the solid tumor tissue images for various immune infiltrates and CAR-T targets in Multiple myeloma 👇

HIMC Facility Director, Dr. Seunghee Kim-Schulze was a plenary speaker on "The critical role of Immune Monitoring in the era of Cancer Immunotherapy" at the 22nd Annual Symposium of the Korean Society of Medical Oncology in Seoul, Korea. Truly remarkable achievement! 👏

Engaging HIMC seminar led by Dr. Virginia Corbett @GinnyCorbett4 of @MountSinaiNYC, who will assess frequency of CHIP before/after PRRT on neuroendocrine tumors by NGS; and profile cytokines using our @OlinkProteomics Target 96-plex Inflammatory & Immuno-Oncology Panel!

The HIMC keeps on top of advances in spatial tissue profiling! Rachel Brody of @MountSinai_Path showing us how bladder cancer histology reveals immune aggregates at the tumor periphery, or interspersed within the tumor mass, suggesting discrete areas of active immune response.👇